RxDoctor Payments DataLook up a doctor →

Mary Stedman, MD

Forensic Psychiatry · Tampa, FLNPI 1457304644

Payments from drug & device makers

$4,609,164in general payments, 2019–2025

Across 1,065 payments — averaging $4327.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$1.5M
  • Eli Lilly$1.5M
  • Livanova USA, Inc.$1M
  • Biogen$156K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$92K
  • Janssen Research & Development, LLC$64K
  • plus $233K from 28 others
$72,044in research payments, 2019–2025

Across 30 payments — averaging $2401.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$59K
  • Acadia Pharmaceuticals Inc$11K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3K

What the payments were for

  • Speaking & faculty fees$5,20027%
  • Travel & lodging$3,46418%
  • Food & beverage$10,35054%
  • Education$860%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few forensic psychiatry providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$39,184
Medicare patients
35
Services billed
412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl21$43,107
AuvelityDextromethorphan Hbr/Bupropion24$25,692
RexultiBrexpiprazole12$19,404
Vilazodone Hcl25$3,076
Lamotrigine49$739
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$651
Buspirone Hcl32$641
Venlafaxine Hcl ErVenlafaxine Hcl12$613
Bupropion XlBupropion Hcl24$603
Quetiapine Fumarate26$580
Clonazepam48$441
Alprazolam68$356
Zolpidem Tartrate ErZolpidem Tartrate11$284
Trazodone Hcl20$229
Imipramine Hcl13$226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$590$43,10721 claims
Axsome Therapeutics, Inc.Auvelity$595$25,69224 claims
Otsuka America Pharmaceutical, Inc.Rexulti$920$19,40412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few forensic psychiatry providers in Floridaon file to place this against a meaningful peer group, so we don't.

Other forensic psychiatry in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →